Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study for Treatment With TH-4000 (Tarloxotinib) in Epidermal Growth Factor Receptor (EGFR) Mutant, T790M-negative Non-small Cell Lung Cancer (NSCLC) Patients

Rain Oncology Inc · 2015
ClinicalTrials.gov · Datasets · License: Public Domain · 2015
Open Source ↗
hypoxianon-small-cell-lung-cancernsclcsquamous-cell-carcinoma
non-small cell lung cancer, nsclc, non-squamous nsclc, th-4000, low-oxygen conditions, hypoxia, squamous cell carcinoma, tarloxotinib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 886523
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.